Nanobodies Outperform Antibodies – Rapid Functionalization with Equal In Vivo Targeting Properties (Adv. Mater. 52/2024)

Documenti analoghi

• Nanobodies Outperform Antibodies – Rapid Functionalization with Equal In Vivo Targeting Properties
  di: Carina Jung, et al.
  Pubblicazione: (2024)
• cDC1 Subtype‐Specific In Vivo Targeting of Liposomes
  di: Maximilian Schaaf, et al.
  Pubblicazione: (2026)
• Interfacial Denaturation at the Droplet Simplifies the Formation of Drug‐Loaded Protein Nanocapsules to Enhance Immune Response of Cells
  di: Sharafudheen Pottanam Chali, et al.
  Pubblicazione: (2024)
• Controlled Functionalization Strategy of Proteins Preserves their Structural Integrity While Binding to Nanocarriers (Adv. Mater. Interfaces 30/2024)
  di: Ana Mateos‐Maroto, et al.
  Pubblicazione: (2024)
• Tuning the Functional Properties of Nanocarriers Using Tunable Nano‐Biointerfaces
  di: Alessia Pancaro, et al.
  Pubblicazione: (2025)